SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 351 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $262,000 | +13.4% | 1,538 | -6.4% | 0.98% | +681.7% |
| Q3 2020 | $231,000 | -17.2% | 1,644 | -5.7% | 0.13% | -23.6% |
| Q2 2020 | $279,000 | -12.5% | 1,743 | -29.6% | 0.16% | +19.6% |
| Q1 2020 | $319,000 | 0.0% | 2,475 | 0.0% | 0.14% | +22.1% |
| Q4 2019 | $319,000 | -12.6% | 2,475 | +3.2% | 0.11% | -21.5% |
| Q2 2019 | $365,000 | -61.3% | 2,399 | -69.7% | 0.14% | -58.7% |
| Q1 2019 | $943,000 | +20.6% | 7,914 | +10.4% | 0.35% | -63.3% |
| Q4 2018 | $782,000 | – | 7,166 | – | 0.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |